经典三重疗法的有效性与替代疗法相比,用于消除H. pylori: 一个系统的审查
1Department of Internal Medicine, College of Medicine, Jazan University, Jazan 45142, Saudi Arabia.
Medicina (Kaunas, Lithuania)
|October 29, 2025
概括
对于Helicobacter pylori的经典三重疗法由于抗生素耐药性,效果较差. 像四倍或连续疗法这样的替代疗法为H. pylori感染提供了更高的根除率.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 杆菌感染是导致胃潰瘍疾病,胃炎和胃癌的主要原因.
- 由于抗生素耐药性增加,经典三重疗法 (CTT) 的有效性正在下降.
- 评估替代H. pylori根除策略至关重要.
研究的目的:
- 将CTT的有效性与其他H. pylori根除方案进行比较.
- 总结有关不同治疗方案的不良事件和患者坚持的数据.
- 评估抗生素耐药性对治疗结果的影响.
主要方法:
- 2000-2025年主要数据库 (PubMed,Scopus,科学网,科克兰图书馆) 的系统文献搜索.
- 包括随机试验和观察性研究来评估H. pylori根除率.
- 使用标准化工具进行数据提取和偏差评估 (Cochrane RoB,纽卡斯尔-太华尺度).
主要成果:
- 分析了13项研究 (n=3490),显示CTT根除率从61.9%到88.8%.
- 连续的,以木为基础的四倍和高剂量的PPI疗法显示出更高的根除率 (>90%).
- 副作用一般为轻度至中度,最常见的是四重疗法,但坚持性仍然很高 (>90%).
结论:
- 在H. pylori抗生素耐药性较高的地区,CTT的有效性显著下降.
- 四倍,序列和高剂量的PPI疗法提供了优越的H. pylori根除结果.
- 建议通过抗生素敏感性测试指导区域特定的治疗策略.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
01:26Peptic Ulcer Disease IV: Management
427
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
427
01:23Gastritis III: Clinical Manifestations and Management
1.2K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
532
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
532
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
928
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
928